Your Cart

Q&A Session at 2022 Annual General Meeting

Q&A Session at 2022 Annual General Meeting

Imagion Biosystems recording of the Q&A session at the 2022 Annual General Meeting.

Imagion Biosystems’ board of directors answer questions from shareholders at the AGM Meeting 2022.


Other AGM meeting links: 

Questions about this session or other investor-related inquiries? Please email our investor relations department at: investor@imagionbio.com.

Related Articles

1H2023 Half-Year Results

1H2023 Highlights: Achieved enrolment target for Phase I study of MagSense® HER2 breast cancer detection; imaging results corroborated by independent panel of radiologists Announced plan

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.